Topic: Cardiovascular disease - Primary Care
Friday, 08 March 2019
In the 70 years since the NHS was founded there have indeed been remarkable successes in reducing mortality from common conditions, an important example being deaths due to heart and circulatory disease. Yet the statistics show that there is more to be done to prevent the toll of premature death and years of disability associated with CVD. For this reason, we welcome the continuing focus on CVD prevention as set out in this publication, produced with the support of PHE and NHS England.
Tuesday, 23 January 2018
A review of guidelines on the use of statins for primary prevention suggest that US, Canadian and UK guidelines, which recommend lower thresholds for people to receive statins, are more effective than European recommendations.
Monday, 01 April 2019
The Public Health England (PHE) action plan for 2017-181 outlined the scale of the cardiovascular disease (CVD) issue we face here in the UK. Affecting around 7 million people, CVD remains a significant cause of disability and death. In England, we know that it is responsible for one in four premature deaths and over a quarter of all deaths, which not only affect the individual but also their families, and impact the wider community too. Healthcare costs associated with CVD are estimated at £8.96 billion and non-healthcare costs at about £4.04 billion. 2 A recent report discusses the evidence for the success of population-based CVD prevention programmes in reducing the burden of illness for individuals and society.
Monday, 01 April 2019
The NHS Health Check is a national programme offering a health check-up every five years to adults in England aged 40 to 74 without a pre-existing cardiovascular condition. One of the largest prevention programmes of its type in the world, the programme is designed to help prevent and detect early signs of heart disease, stroke, kidney disease, type 2 diabetes and dementia. 1 This article reviews the evidence that has accumulated since the programme was established.
Thursday, 14 March 2019
There appears to be an association between migraine and cardiovascular disease and especially ischaemic stroke. How real is the absolute risk, what may be the cause, and what, if anything should we tell our patients?
Thursday, 04 October 2018
People that sleep for more than 8 hours a night have a greater mortality and cardiovascular risk than those who sleep for under seven hours, according to a recent systematic review published in the Journal of the American Heart Association. The study also found that a sleep duration of 10 hours is linked with a 30% increased mortality risk compared to sleeping for seven hours.
Thursday, 16 August 2018
Increased physical activity, not weight loss, gives individuals with coronary heart disease (CHD) including angina and myocardial infarction a longer lifespan, according to a new long-term Norwegian study.
Tuesday, 27 February 2018
Chris Arden, Editor-in-chief of the Primary Care Cardiovascular Journal With New Year fading into the distance and the days getting longer, our attention focuses on what this year will bring in cardiovascular disease and diabetes.
Wednesday, 06 December 2017
Percutaneous coronary intervention (PCI) is not significantly better than a placebo procedure in improving exercise capacity or symptoms even in patients with severe coronary stenosis, according to new UK research. The ORBITA study is the first double blind randomised controlled trial to directly compare stenting with placebo in patients with stable angina who are receiving high quality drug treatment.
Wednesday, 21 February 2018
Hypertension is the most important single risk factor for cardiovascular disease (CVD). It affects over 25% of adults in England, but more than 5.5 million people remain undiagnosed. Although the number of adults with untreated hypertension has fallen, England’s performance still lags behind achievements in countries such as Canada and the USA, and there is scope for improvement.